JITC

Comments on roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
Maria Jose Serrano, Umberto Malapelle

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006106; DOI: 10.1136/jitc-2022-006106
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Hongping Ba, Zigang Dai, Zunyue Zhang, Peng Zhang, Bingjiao Yin, Jing Wang, Zhuoya Li, Xiaoxi Zhou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e003837; DOI: 10.1136/jitc-2021-003837
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
Mario Sznol, Naiyer Rizvi

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006346; DOI: 10.1136/jitc-2022-006346
Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy
Lin Shi, Jinying Lu, Da Zhong, Meijuan Song, Jian Liu, Wenhua You, Wen-Hui Li, Lin Lin, Dongyan Shi, Yun Chen

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005902; DOI: 10.1136/jitc-2022-005902
Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells
Aram Lee, Haesun Park, Soyoung Lim, Jihyun Lim, Jaemoon Koh, Yoon Kyung Jeon, Young Yang, Myeong-Sok Lee, Jong-Seok Lim

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005699; DOI: 10.1136/jitc-2022-005699
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
Mark D. Stewart, Valsamo Anagnostou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006367; DOI: 10.1136/jitc-2022-006367
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer
Julia Karbach, Dragan Kiselicki, Kathrin Brand, Claudia Wahle, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Hans-Bernd Prisack, Akin Atmaca, Elke Jäger

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005847; DOI: 10.1136/jitc-2022-005847
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
Lavanya Sivapalan, Joseph C Murray, Jenna VanLiere Canzoniero, Blair Landon, Jennifer Jackson, Susan Scott, Vincent Lam, Benjamin P. Levy, Mark Sausen, Valsamo Anagnostou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005924; DOI: 10.1136/jitc-2022-005924
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo de Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N Sternberg

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005977; DOI: 10.1136/jitc-2022-005977
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006072; DOI: 10.1136/jitc-2022-006072

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages